About USAMRIID

Scientific Publications

Business Opportunities

Employment

Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

— 2000 —

Bray M, Driscoll J, Huggins JW.  2000.  Treatment of lethal Ebola virus infection with a single dose of an A-adenosyl-L-homocysteine hydrolase inhibitor.  Antivir Res 45:135-147.

Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW.  2000.  Cidofovir (HPMPC) protects mice against lethal aerosol or intranasal cowpox virus challenge.  J Infect Dis 181:10-19.

Byrne MP, Titball R, Holley J, Smith LA.  2000.  Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris.  Protein Expression Purif 18:327-337.

Cieslak TJ, Christopher GW, Kortepeter MG, Rowe JR, Pavlin JA, Culpepper RC, Eitzen Jr EM.  2000.  Immunization against potential biological warfare agents.  Clin Infect Dis 30:843-850.

Cieslak TJ, Eitzen Jr EM.  2000.  Bioterrorism: Agents of concern.  J Pub Hlth Manage Prac 6:19-29.

Clayton J, Middlebrook JL.  2000.  Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A.  Vaccine 18:1855-1862.

Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB.  2000.  Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.  Lab Invest 80:171-186.

Gilligan K, Shipley M, Stiles B, Hadfield TL, Ibrahim MS.  2000.  Identification of Staphylococcus aureus enterotoxins A and B genes by PCR-ELISA.  Molec Cell Probes 14:71-78.

Hail AS, Rossi CA, Ludwig GV, Ivins BE, Tammariello RF, Henchal EA.  1999.  Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure.  Milit Med 164:833-837.

Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL.  2000.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.  Virology 266:329-339.

Jahrling PB, Zaucha GM, Huggins JW.  2000.  Countermeasures to the reemergence of smallpox virus as a agent of bioterrorism, pp 187-200.  In WM Scheld, WA Craig, JM Hughes, Emerging Infections 2000, ASM Press, Washington DC.

Kijek TM, Rossi CA, Moss D, Parker RW, Henchal EA.  2000.  Rapid and sensitive immunomagnetic electrochemiluminescent detection of staphylococcal enterotoxin B.  J Immunol Meth 236:9-17.

Krakauer T.  2000.  Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small non-peptidic inhibitor of class II major histocompatibility complex and CD4 interaction.  Antimicrob Agents Chemother 44:1067-1069.

Macintyre AG, Christopher GW, Eitzen Jr E, Gum R, Weir S, DeAtley C, Tonat K, Barbera JA.  2000.  Weapons of mass destruction events with contaminated casualties.  Effective planning for health care facilities.  JAMA 283:242-249.

Martinez MJ, Bray MP, Huggins JW.  2000.  A mouse model of aerosol-transmitted orthopoxviral disease: Morphology of experimental aerosol-transmitted orthopox viral disease in a cowpax virus-BALBlc mouse system.  Arch Pathol Lab Med 124:362-377.

McClain DJ, Summers P, Harrison S, Schmaljohn AL, Schmaljohn CS.  2000.  Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine.  J Med Virol 60:77-85.

Meyer BC, Schmaljohn C.   2000.  Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence.  J Virol 74:1321-1331.

Meyer BC, Schmaljohn C.   2000.  Persistent hantavirus infections: Characteristics and mechanisms.  Trends Microbiol 8:61-67.

Montgomery VA, Makuch RS, Brown JE, Hack DC.  2000.  The immunogenicity in humans of a botulinum type F vaccine.  Vaccine 18:728-735.

Poli MA, Musser SM, Dickey RW, Eilers PP, Hall S.  2000.  Neurotoxic shellfish poisoning and brevetoxin metabolites: A case study from Florida.  Toxicon 38:981-993.

Sheets JT, Rossi CA, Kearney BJ, Moore GE.  1999.  Evaluation of a commercial enzyme-linked immunosorbent assay (ELISA) for detection of Borrelia burgdorferi exposure in dogs.  J Am Vet Med Asso 216:1418-1422.

Stiles BG, Hale ML, Marvaud J-C, Popoff MR.  2000.  Clostridium perfringens iota toxin: Binding studies and characterization of cell surface receptor by fluorescence-activated cytometry.  Infect Immun 68:3475-3484.

Turell MJ, O'Guinn M, Oliver J.  2000.  Potential for New York mosquitoes to transmit West Nile virus.  Am J Trop Med Hyg 62:413-414.

Ulrich RG.  2000.  Evolving superantigens of Staphylococcus aureus.  FEMS Immunol Med Microbiol 27:1-7.

Vaughan JA, Trpis M, Turell MJ.  1999.  Brugia malayi microfilariae (Nematoda:Filaridae) enhance the infectivity of Venezuelan equine encephalitis virus to Aedes mosquitoes (Diptera:Culicidae).  J Med Entomol 36:758-763.

Vlach KD, Stiles BG, Boles JW.  2000.  Telemetric evaluation of temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock.  Comp Med 50:160-166.

Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK.  2000.  Epitopes involved in antibody-mediated protection from Ebola virus.  Science 287:1664-1666.

Privacy & Security Notice  |  External Links Disclaimer  |  Information Collected  |  Freedom of Information Act (FOIA)  |  No Fear Act Data  |  Office of Special Counsel
Web Accessibility  |  Accessibility/Section 508  |  Last Modified:  06/25/2020

This Web site provides an introduction to the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and contains official information.
It is intended for interested members of the public, news media and Army Medical Department beneficiaries.
Please address questions and concerns about this website to the USAMRIID Webmaster via email.